| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $610.3M | +7.5% |
| Cost of Revenue | $350.7M | +5.0% |
| Gross Profit | $259.6M | +11.2% |
| R&D Expense | $11.4M | +36.0% |
| SG&A Expense | $183.1M | +15.7% |
| Operating Income | $67.4M | +0.9% |
| Pre-tax Income | $62.3M | +15.0% |
| Income Tax | $18.2M | +0.6% |
| Net Income | $44.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.9M | -1.6% |
| Accounts Receivable | $110.6M | +18.3% |
| Inventory | $100.3M | +21.8% |
| Current Assets | $365.9M | +11.7% |
| Total Assets | $770.0M | +18.0% |
| Current Liabilities | $104.5M | +11.0% |
| Long-term Debt | $291.0M | +37.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.7M | +100.5% |
| Capital Expenditures | $6.9M | +21.0% |
| Investing Cash Flow | -$96.4M | +34.6% |
| Financing Cash Flow | $31.6M | -79.3% |
| Free Cash Flow | $56.8M | +117.7% |
| +22.2% |
| EPS (Basic) | $1.08 | +20.0% |
| EPS (Diluted) | $1.02 | +13.3% |
| Total Liabilities |
| $452.2M |
| +32.5% |
| Stockholders' Equity | $317.8M | +2.0% |